Full Episode
Saturday, Oct 4
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

A free press is a cornerstone of a healthy democracy

Support trusted journalism and civil dialogue
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

johnson & johnson

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Feb 27

Watch 5:50
J&J vaccine: Fight against COVID-19 gets another shot in the arm

By PBS NewsHour

Vaccination efforts to fight the pandemic got another shot in the arm. The Johnson & Johnson vaccine, which is expected to rollout soon after the FDA nod, will speed up inoculations against COVID-19, but it might be a while before…

Continue watching

Feb 26

FDA advisory panel endorses single-shot COVID-19 vaccine from Johnson & Johnson

By Lauren Neergaard, Matthew Perrone, Associated Press

The FDA is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorized for emergency use in the U.S. Shipments of a few million doses could begin as early as Monday.

Continue reading

Feb 26

How does the Johnson & Johnson vaccine compare to other coronavirus vaccines?

By Maureen Ferran, The Conversation

The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to global vaccination efforts.

Continue reading

Feb 26

WATCH: FDA committee endorses emergency use for Johnson & Johnson COVID-19 vaccine

By Associated Press

If granted emergency use, Johnson & Johnson's vaccine would be the third available vaccine in the United States, but the first to require one dose rather than two.

Continue reading

Feb 24

FDA says Johnson & Johnson’s single-dose shot protects against COVID-19

By Lauren Neergaard, Matthew Perrone, Associated Press

An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19.

Continue reading

Feb 04

Johnson & Johnson asks U.S. regulators to approve its one-shot COVID-19 vaccine

By Lauren Neergaard, Associated Press

Preliminary results from a massive study showed J&J's vaccine was safe and offered strong protection against moderate to severe COVID-19.

Continue reading

Jan 29

Johnson & Johnson’ single-shot vaccine is 66 percent effective against COVID-19

By Lauren Neergaard and Linda A. Johnson, Associated Press

With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters.

Continue reading

Oct 23

AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines

By Linda A. Johnson, Associated Press

Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval.

Continue reading

Sep 23

Late-stage study of first single-shot vaccine begins in U.S.

By Linda A. Johnson, Associated Press

Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus.

Continue reading

Nov 15

Oklahoma judge reduces J&J order in opioid lawsuit by $107 million

By Sean Murphy, Ken Miller, Associated Press

An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis on Friday reduced that amount by $107 million in a final order in the case.

Continue reading

Jump to the First Page Previous Page
1 3 4 5 6 7
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Saturday, Oct 4
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You